155 results on '"Kang, Dong Yoon"'
Search Results
2. Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry
3. Development and Feasibility Evaluation of Smart Cancer Care 2.0 Based on Patient-Reported Outcomes for Post-Discharge Management of Patients with Cancer
4. Effect of weekend catch-up sleep on high-sensitivity C-reactive protein levels according to bedtime inconsistency: a population-based cross-sectional study
5. Validation of Practical Pathway in Patients With Anaphylaxis to Low Osmolar Contrast Media: A Retrospective Cohort Study
6. Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored HLA genotypes
7. Active Surveillance of Cytomegalovirus Infection, Pneumocystis Pneumonia, and Pulmonary Aspergillosis in Critically Ill Patients with COVID-19
8. A Patient Management System Using an Edge Computing-Based IoT Pulse Oximeter
9. Risk factors of beta-lactam anaphylaxis in Korea: A 6-year multicenter retrospective adult case-control study
10. A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea
11. Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level
12. A One-Bag Rapid Desensitization Protocol for Paclitaxel Hypersensitivity: A Noninferior Alternative to a Multi-Bag Rapid Desensitization Protocol
13. MetaLAB‐HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records
14. Comparison of Cefazolin/Metronidazole to Ampicillin/Sulbactam as Preoperative Antibiotics in Colorectal Surgery: A Retrospective, Single-Center Cohort Study
15. Comparison of Cefazolin/Metronidazole versus Ampicillin-Sulbactam as Preoperative Antibiotics in Colorectal Surgery: Retrospective, Single-Center Cohort Study
16. Unique Clinical Characteristics and Prognosis of Allopurinol-Induced Severe Cutaneous Adverse Reactions
17. The Presence of HLA-B75, DR13 Homozygosity, or DR14 Additionally Increases the Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in HLA-B*58:01 Carriers
18. Incidence and Risk of Oxaliplatin-Induced Hypersensitivity in Patients with Asymptomatic Prior Exposure: A Prospective Observational Study
19. MetaLAB‐HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records.
20. Investigation of hepatic adverse events due to quetiapine by using the common data model.
21. HLA-DRB1*15: 02 Is Associated With Iodinated Contrast Media–Related Anaphylaxis
22. Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers
23. Acute Adverse Reactions to Nonionic Iodinated Contrast Media: A Meta-Analysis
24. Adverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study
25. HLA‐A*24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms in HLA‐B*58:01 carriers in a Korean population; a multicenter cross‐sectional case‐control study
26. Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea
27. Allergic-like Hypersensitivity Reactions to Gadolinium-based Contrast Agents: An 8-year Cohort Study of 154 539 Patients
28. Epidemiology and evaluation of adverse drug reactions in a Korean hospital database for spontaneous reports in the period 2009 to 2018
29. Early detection of patients with narcotic use disorder using a modified MEDD score based on the analysis of real-world prescription patterns
30. Risk Factors for Clostridium difficile Infection in Antibiotic Use Inpatients Based on Common Data Model
31. Analysis of Fluoroquinolone Adverse Drug Reaction Reported in a Single Center
32. Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol
33. Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition
34. Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes
35. Increase in eosinophil-derived neurotoxin level in school children with allergic disease
36. Educating Healthcare Professionals in Pharmacovigilance: Global Trends and Korea’s Status
37. Adverse Drug Reactions to First-line Anti-tubercular Drugs Based on Individual Case Safety Report in a Single Tertiary Hospital
38. Drug Labeling Status of Culprit Drugs Inducing Severe Cutaneous Adverse Reactions
39. Surveillance of Adverse Drug Reactions to First-line Antituberculosis Drugs Using Common Data Model
40. Adverse Reactions after the Second Dose of ChAdOx1 COVID-19 Vaccine in Healthcare Workers
41. A 10-Year Single-Center Experience of Adverse Drug Reaction Monitoring
42. Improving the Prescription System to Prevent Adverse Drug Reactions
43. Precautions for COVID-19 Vaccination
44. Finding the Optimal Alternative for Immediate Hypersensitivity to Low-Osmolar Iodinated Contrast
45. Genetic risk markers of carbamazepine-induced severe cutaneous adverse reactions: new candidates in Koreans
46. Carbonic anhydrase inhibitor–induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement
47. Finding the optimal alternative for immediate hypersensitivity to low-osmolar iodinated contrast
48. HLA-DRB1*15:02 Is Associated With Iodinated Contrast Media–Related Anaphylaxis
49. Educating Healthcare Professionals in Pharmacovigilance: Global Trends and Korea’s Status
50. Analysis of individual case safety reports of drug-induced anaphylaxis to the Korea Adverse Event Reporting System
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.